drugset
drugset / Trial / NCT05137626

Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)

NCT05137626 ↗

Phase 1 Completed 29 enrolled Atea Pharmaceuticals, Inc. Hoffmann-La Roche · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Drug-drug interaction study of Digoxin and AT-527 (R07496998)

Timeline

Start
2021-11-03
Primary completion
2021-12-12
Completion
2021-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemnifosbuvir Other / unclassified — —
Subject Digoxin Other / unclassified — —

Indications

No indication recorded.